Switch to:

Ratios

vs
industry
vs
history
PE Ratio 18.02
KYE's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KYE: 18.02 )
Ranked among companies with meaningful PE Ratio only.
KYE' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 20.72
Current: 18.02
0
20.72
PE Ratio without NRI 18.02
KYE's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KYE: 18.02 )
Ranked among companies with meaningful PE Ratio without NRI only.
KYE' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 20.72
Current: 18.02
0
20.72
PB Ratio 1.82
KYE's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KYE: 1.82 )
Ranked among companies with meaningful PB Ratio only.
KYE' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 1.82
0
2.3

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 7.82
KYE's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KYE: 7.82 )
Ranked among companies with meaningful Dividend Yield % only.
KYE' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 12.21
Current: 7.82
0
12.21
5-Year Yield-on-Cost % 7.82
KYE's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KYE: 7.82 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
KYE' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 12.21
Current: 7.82
0
12.21

More Statistics

Short Percentage of Float0.00%
52-Week Range $6.71 - 12.97
Shares Outstanding (Mil)36,558,050.00
» More Articles for KYE

Headlines

Articles On GuruFocus.com
Easy and Practical Framework to Invest Like Buffett and Beyond Feb 23 2017 
David Einhorn: Trump Bringing Inflation, ‘High Degree’ of Uncertainty Feb 23 2017 
Trump's Tax Policy May Make for Some Very Easy Investing Feb 23 2017 
Dividend Aristocrat on the Rebound Feb 23 2017 
Is Nu Skin's 11% Earnings Drop an Overreaction? Feb 23 2017 
Weekly CFO Buys Highlights Feb 23 2017 
Weekly CFO Sells Highlights Feb 23 2017 
Beat the Market With a Water ETF Feb 23 2017 
How to Not Lose Everything When Buying Micro-Caps Feb 23 2017 
Jamba Insider Continues to Load Up on Shares Feb 23 2017 

More From Other Websites
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Feb 02 2017
KAYNE ANDERSON ENERGY TOTAL RETURN FUND, INC. Financials Feb 01 2017
Kayne Anderson Files 2016 Annual Reports for KYN, KYE, KMF and KED Jan 27 2017
Kayne Anderson Announces Tax Characterization of 2016 Distributions for KYN, KYE, KMF and KED Jan 27 2017
5arg">Ares and Kaynergy Total Return Fund Announces Distribution of $0.25 per ormation and Announces... Jan 06 2017
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Jan 04 2017
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Jan 04 2017
Kayne Anderson Energy Total Return Fund Announces Distribution of $0.25 per Share for Q4 2016 Dec 15 2016
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Dec 02 2016
Aegerion Pharmaceuticals' JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial... Nov 17 2016
Aegerion Pharmaceuticals Appoints John Orloff, M.D., as Executive Vice President, Head of R&D Nov 04 2016
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results Nov 03 2016
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Nov 01 2016
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Nov 01 2016
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Oct 03 2016
Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces... Oct 03 2016
Kayne Anderson Energy Total Return Fund Announces Distribution of $0.25 per Share for Q3 2016 Sep 29 2016
Kayne Anderson Energy Total Return Fund Announces Distribution of $0.25 per Share for Q3 2016 Sep 29 2016
Aegerion Pharmaceuticals' JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of... Sep 28 2016
Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day Sep 24 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK